FibroGen Inc (FGEN)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current FGEN market cap is 127.83M. The company's latest EPS is USD -2.8573 and P/E is -0.45.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 36.16M | 44.32M | 40.13M | 27.14M | 55.9M |
| Operating Income | -76.09M | -88.05M | -63.48M | -54.2M | -31.06M |
| Net Income | -76.71M | -87.68M | -63.62M | -56.23M | -32.93M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 256.58M | 176.32M | 235.31M | 140.73M | 147.75M |
| Operating Income | -89.31M | -192.08M | -287.52M | -299.45M | -281.82M |
| Net Income | -76.97M | -189.29M | -290.02M | -293.65M | -284.23M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 538.54M | 515.13M | 460.43M | 423.53M | 365.87M |
| Total Liabilities | 567.43M | 575.43M | 575.63M | 585.73M | 552.02M |
| Total Equity | -28.89M | -81.79M | -136.68M | -183.68M | -207.64M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 857.4M | 826.84M | 773.82M | 610.09M | 423.53M |
| Total Liabilities | 321.99M | 385.39M | 544.71M | 611.57M | 585.73M |
| Total Equity | 535.41M | 441.45M | 229.11M | -1.48M | -183.68M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -101.59M | -212.16M | -296.7M | -315.02M | -59.29M |
| Investing | 103.48M | 89.2M | 143.42M | 153.66M | 51.28M |
| Financing | 31.49M | 123.02M | 123M | 122.75M | -165k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -78.71M | 81.6M | -82.23M | -145.93M | -315.02M |
| Investing | 120.02M | 452.49M | -426.97M | 89.12M | 153.66M |
| Financing | -4.3M | 13.34M | -563k | 46.78M | 122.75M |
| Market Cap | 127.83M |
| Price to Earnings Ratio | -0.45 |
| Price to Sales Ratio | 0.86 |
| Price to Cash Ratio | 1.12 |
| Price to Book Ratio | -0.79 |
| Dividend Yield | - |
| Shares Outstanding | 99.48M |
| Average Volume (1 week) | 1.67M |
| Average Volume (1 Month) | 2.74M |
| 52 Week Change | -39.95% |
| 52 Week High | 2.93 |
| 52 Week Low | 0.3333 |
| Spread (Intraday) | 0.01 (0.78%) |
| Company Name | FibroGen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.fibrogen.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
